PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Research reveals new therapeutic target for Huntington's disease

2014-01-08
(Press-News.org) Contact information: Kathy Wallis
kwallis3@uwo.ca
519-661-2111 x81136
University of Western Ontario
Research reveals new therapeutic target for Huntington's disease VIDEO: Stephen Ferguson, Ph.D., a scientist at Western University's Robarts Research Institute found a definite improvement in motor behaviours in a Huntington's disease mouse model when one of the major neurotransmitters...
Click here for more information.

Research from Western University (London, Canada) has revealed a possible new target for treating movement disorders such as Huntington's disease (HD) and Parkinson's disease. Stephen Ferguson, PhD, a scientist at Western's Robarts Research Institute, and Fabiola Ribeiro, PhD, of the Universidade Federal de Minas Gerais in Brazil found a definite improvement in motor behaviors in a HD mouse model when one of the major neurotransmitters in the brain, called Metabotropic Glutamate Receptor 5 (mGluR5) was deleted. The research is published online in Human Molecular Genetics.

HD is an inherited neurodegenerative disorder which causes uncontrolled movement, and eventually cognitive decline and emotional disturbances.

Working in the Ferguson lab where Ribeiro was a postdoctoral trainee, the scientists crossed two mouse models. One was a mouse which doesn't have glutamate receptors –they've been knocked out genetically, and the other is a HD mouse model which over-expresses mutant human Huntington protein. They found if they deleted mGluR5, they lost the pathology of Huntington's in the neurons, and they saw improvements in motor behavior which normally would be impaired in these mice.

"What we found was, if we block mGluR5, which is the glutamate receptor we're interested in, the mice become hyper locomotive so they become able to move better than wild type mice suggesting glutamate receptors might be a good target for treating movement disorders such as Parkinson's disease. So that was a bit of a surprise that came out in the study, and we can show that genetically and pharmaceutically," says Ferguson who holds a Canada Research Chair in Molecular Neurobiology. "And the good thing is, there are mGluR5 antagonists now in stage three clinical trials for diseases such as Fragile X, so it is quite possible these drugs will be available for patients in the future."

### END


ELSE PRESS RELEASES FROM THIS DATE:

Geography has impact on grapevine moth's success in French vineyards

2014-01-08
Geography has impact on grapevine moth's success in French vineyards Study sheds light on how regional differences, local temperatures influence immune function of pests 'Location, location, location' is an adage also true for the European grapevine moth, it seems. Research ...

Laundering money -- literally -- could save billions of dollars

2014-01-08
Laundering money -- literally -- could save billions of dollars A dollar bill gets around, passing from hand to hand, falling on streets and sidewalks, eventually getting so grimy that a bank machine flags it and sends it to the shredder. Rather than destroying ...

Newly discovered celestial object defies categories

2014-01-08
Newly discovered celestial object defies categories Scientists asking if it is a new kind of planet or a rare kind of failed star TORONTO, ON – An object discovered by astrophysicists at the University of Toronto (U of T) nearly 500 light years away from the Sun ...

Metal ink could ease the way toward flexible electronic books, displays

2014-01-08
Metal ink could ease the way toward flexible electronic books, displays Scientists are reporting the development of a novel metal ink made of small sheets of copper that can be used to write a functioning, flexible electric circuit on regular printer paper. ...

Green space can make people happier for years

2014-01-08
Green space can make people happier for years Nearly 10 years after the term "nature deficit disorder" entered the nation's vocabulary, research is showing for the first time that green space does appear to improve mental health in a sustained way. The report, ...

Top chemical advances and more from the year 2013

2014-01-08
Top chemical advances and more from the year 2013 From stretchy electronics to Martian chemistry, the most notable advances in the chemical world in 2013 appear in the year-in-review issue of Chemical & Engineering News (C&EN), the weekly newsmagazine of the ...

AML score that combines genetic and epigenetic changes might help guide therapy

2014-01-08
AML score that combines genetic and epigenetic changes might help guide therapy COLUMBUS, Ohio – Currently, doctors use chromosome markers and gene mutations to determine the best treatment for patients with acute myeloid leukemia (AML). ...

Cosmetic outcomes after breast-conserving therapy may vary by race

2014-01-08
Cosmetic outcomes after breast-conserving therapy may vary by race Subjective ratings appear lower in African-American patients, reports PRS Global Open Philadelphia, Pa. (January 7, 2013) – As perceived by both patients and doctors, the cosmetic results ...

Stopping tumors in their path

2014-01-08
Stopping tumors in their path New study sheds light on most common and deadly form of brain cancer Glioblastoma (GBM) is the most common and deadly form of primary malignant brain cancer accounting for approximately 15% of all brain tumours and occurring mostly in adults between ...

Study shows women continue to outlive men as numbers of centenarians on the rise

2014-01-08
Study shows women continue to outlive men as numbers of centenarians on the rise TORONTO, January 8, 2014 – The number of centenarians in Ontario increased by more than 70 per cent over the last 15 years with women making up more than 85 per cent ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Research reveals new therapeutic target for Huntington's disease